DelveInsight has launched a new report on Medulloblastoma Epidemiology
Medulloblastoma is classified as a primitive neuroectodermal tumor, typically occurring in the cerebellar vermis which is located in the posterior fossa of the skull. This tumor accounts for 40% of those arising from the posterior fossa.
Request for free sample copy- https://www.delveinsight.com/sample-request/medulloblastoma-market
Medulloblastoma Epidemiology historical as well as forecasted Medulloblastoma epidemiology in 7MM, covering the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan from 2018 to 2030
Medulloblastoma Epidemiology
According to Orphanet, Medulloblastoma (MB) is the most common malignant brain tumor in childhood. Annual incidence varies according to age a group, and is estimated in the USA at 0.47/100,000 in children (0-14 years of age), 0.11/100,000 in adolescents and young adults, 0.02/100,000 in adults (over 40 years of age). Males are more affected than females
Key facts of Medulloblastoma Epidemiology
- Analysis of data from the English national cancer registry for all patients diagnosed with Medulloblastoma during 2001–2015, in England, demonstrated the overall average crude incidence rate as 0.12 per 100,000 (2001–2015), with no significant trend between 5-year periods. However, the incidence rate for the age groups 0–3 and 4–14 was significantly higher than the older age groups. Male incidence was significantly higher than female (Khann et al., 2018)
- Analysis of data from Central Brain Tumor Registry of the United States (CBTRUS) from 2001 to 2013 demonstrated that Medulloblastoma incidence remained relatively stable from 2001 to 2013, with minor fluctuations from 2001 to 2009 (APC = 2.2, 95% CI 0.8, 3.5) and 2009-2013 (APC = -4.1, 95% CI -7.5, -0.6). Incidence was highest in patients aged 1-4 years at diagnosis, but patients aged 10-14 years showed increased incidence from 2000 to 2013 (APC = 3.2, 95% CI 0.6, 5.8) (Khanna et al, 2018)
- According to DelveInsight’s analysis, Medulloblastoma is more common in males, affecting approximately 1.7 times more males than females
Medulloblastoma Epidemiology Segmentation
- Total Incident cases of Medulloblastoma in the 7MM [2018–2030]
- Age-specific cases of Medulloblastoma [2018–2030]
- Gender-specific cases of Medulloblastoma [2018–2030]
Medulloblastoma Symptoms
The symptoms of medulloblastoma usually result from increased pressure within the skull (intracranial pressure). Many infants and children develop papilledema, a condition in which the optic nerve swells because of increased intracranial pressure. Additional symptoms may include irritability, increased head size, and paralysis (paresis) of the muscles that help control eye movements (extraocular muscles).
Medulloblastoma Report Scope
- The report covers the descriptive overview of Medulloblastoma, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Medulloblastoma epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Medulloblastoma are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Medulloblastoma market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Medulloblastoma market
Request for free sample copy- https://www.delveinsight.com/sample-request/medulloblastoma-market
Table of content
1. Key Insights
2. Executive Summary of Medulloblastoma
3. Competitive Intelligence Analysis for Medulloblastoma
4. Medulloblastoma: Market Overview at a Glance
5. Medulloblastoma: Disease Background and Overview
6. Patient Journey
7. Medulloblastoma Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Medulloblastoma Treatment
11. Marketed Products
12. Emerging Therapies
13. Medulloblastoma: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Medulloblastoma
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
What will be the key questions answered?
- What was the Medulloblastoma market share (%) distribution in 2017 and how it would look like in 2030?
- What would be the Medulloblastoma total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Medulloblastoma market size during the forecast period (2017-2030)?
- At what CAGR, the Medulloblastoma market is expected to grow in 7MM during the forecast period (2017-2030)?
- What would be the Medulloblastoma market outlook across the 7MM during the forecast period (2017-2030)?
- What would be the Medulloblastoma market growth till 2030, and what will be the resultant market Size in the year 2030?
- How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?
Reasons to buy
- The report will help in developing business strategies by understanding trends shaping and driving the Medulloblastoma market
- To understand the future market competition in the Medulloblastoma market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Medulloblastoma in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Medulloblastoma market
- To understand the future market competition in the Medulloblastoma market
Related Reports
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/